EMA Authorised: Rasagiline ratiopharm (rasagiline) — Teva B.V.

View source ↗

Summary

EMA authorised Rasagiline ratiopharm (rasagiline) by Teva B.V. for the treatment of Parkinson's disease. It represents a generic entry for rasagiline in the EU.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Rasagiline ratiopharm (rasagiline)

Snippet

Status: Authorised. Therapeutic area: Parkinson Disease. MAH: Teva B.V.. Decision date: 07/04/2025